Why the study?
Does slow intravenous amiodarone restore sinus rhythm and improve hemodynamics in critically ill patients with acute atrial fibrillation or flutter and severely depressed left ventricular function (LVEF < 15%)?
Does slow intravenous amiodarone restore sinus rhythm and improve hemodynamics in critically ill patients with acute atrial fibrillation or flutter and severely depressed left ventricular function (LVEF < 15%)?
Slow intravenous amiodarone (300 mg over 1 hour) is an effective and hemodynamically well-tolerated therapy for acute atrial fibrillation/flutter in critically ill patients with severely depressed LV systolic function.
Answers are grounded in this paper and cite their sources.
May support slow IV amiodarone in severe LV dysfunction; hypothesis-generating and leaves open need for RCTs.
A retrospective review was done to determine the efficacy and hemodynamic effects of slow intravenous amiodarone administration on invasively monitored patients with acute onset of atrial fibrillation or atrial flutter and left ventricular ejection fractions < 15%. Eight patients met predefined inclusion criteria. All received 300 mg amiodarone intravenously over 1 hour. Seven reverted to sinus rhythm within 1 hour, with return of most hemodynamic variables to baseline. Before reversion, each patient experienced a beneficial slowing of heart rate (mean, 28%) resulting in significant improvement of stroke volume index (mean, 49%) and left ventricular stroke work index (mean, 61%). No patient had hemodynamic deterioration attributable to amiodarone infusion. Slow intravenous infusion of amiodarone appears to be an effective and hemodynamically well-tolerated therapy for atrial fibrillation and atrial flutter in critically ill patients with marked depression of left ventricular systolic function.
No takes yet. Share an insight, caveat, or question.
Anand Kumar (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: